SPECIALTY TOPICS · GUIDE

Stem Cells vs Exosomes

Stem cells are living cells; exosomes are tiny particles that cells release. This page compares what each is, the human evidence, US regulatory status and the risks of unapproved products.

Content last updated October 22, 2026. This page has not been medically reviewed.

Back to Emerging Wellness Science

Quick answer

Stem-cell products contain living cells. Exosome products, as marketed, are meant to contain tiny particles released by cells, not the cells themselves. Neither term tells you whether a product is safe, approved or effective. This page compares them and declares no winner. It describes research and regulation; it is not a recommendation for any treatment. Evidence labels used: approved medicine, promising but limited, insufficient evidence, preclinical (cells/animals only), marketing claim.

Definitions

Stem cells are living cells used in cell-based products. Basics are in Stem Cells Explained.
Extracellular vesicles (EVs) are nano-sized membrane-bound particles released from cells. [1] Exosome products are usually discussed under this heading; see Extracellular Vesicles and Exosomes.
The FDA lists stem cells, fat-derived cells, cord blood, amniotic fluid, Wharton's jelly and exosomes together among unapproved products that are broadly marketed as regenerative medicine. [2]

The difference at a glance

	Stem-cell products	Exosome products
What they are	Living cells	Particles released by cells [1]
US approvals (FDA, read 2026-10-22)	Some cell products are licensed for specific uses: the FDA's list includes cord-blood products and Ryoncil, among others [3]	"There are currently no FDA-approved exosome products." [4]
Orthopedic conditions	None of these products have been approved for any orthopedic condition, such as osteoarthritis [5]	Same statement covers exosome products [5]
Human trial evidence	Varies by cell type and condition	25 published clinical studies in one review, only 7 controlled [1]
Safety concerns reported	Blindness, tumor formation, infections [2]	Serious adverse events in Nebraska patients treated with unapproved exosome-labeled products [4]

What the evidence shows

Stem cells. Established uses involve specific, regulated products. The FDA's consumer alert (content current as of April 2024) said the only approved stem-cell products then were blood-forming stem cells from cord blood, for disorders of the blood-forming system. [5] The FDA's list, current as of September 2026, now also names other cell-based products, so check the list for the exact product and indication. [3] Approval of one product does not extend to others with similar names or to other conditions. For a closer look see Cell-Therapy Clinical Trials vs Commercial Treatments.

Exosomes and EVs. A systematic review through September 2024 found 25 published clinical studies of cell-derived EVs; 8 looked at COVID-19 and related lung injury, and 5 at wound healing. Only 7 were controlled, and most EVs came from mesenchymal stromal cells. [1] A pooled analysis of three controlled COVID-19 trials suggested lower mortality, but wound-healing benefit was less clear, and the authors called safety conclusions preliminary because adverse-event reporting was often incomplete. [1] The review described marked heterogeneity between trials, and 17 of the 25 used ultracentrifugation to isolate the particles, so "exosome" products should not be assumed to be interchangeable. [1] Evidence label: promising but limited for those specific research uses; insufficient evidence for the many other conditions clinics advertise.

Frequently asked questions

Are exosomes safer than stem cells because they are not living cells?

That has not been shown. Safety data for exosome products are limited, [1] and the FDA has received reports of serious adverse events after unapproved exosome products. [4]

Is any exosome product FDA-approved?

The FDA says there are currently no FDA-approved exosome products. [4]

Are stem-cell treatments approved for knee arthritis?

The FDA says none of these regenerative products has been approved for orthopedic conditions such as osteoarthritis. [5]

Does a clinical-trial listing mean a product is legal?

No. The FDA says a listing on clinicaltrials.gov does not mean the product is legally marketed. [2]

More details: evidence, limits and cautions

The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.

Risks of unapproved products

The FDA has received reports of blindness, tumor formation and infections from unapproved regenerative products, and lists contamination during processing as a concern. [2] The agency says exosomes used to treat diseases are regulated as drugs and biological products, which require premarket review. [4] It also warns that being listed on clinicaltrials.gov does not mean a product is legally marketed. [2] The FDA has no oversight of treatments done in other countries. [4] Laws differ elsewhere; this page covers the United States only and is not legal advice. See Unapproved Clinics and Medical Tourism for Cell Therapies and Laboratory Findings vs Marketed Exosome Products.

When to get medical help

If you were harmed after a stem-cell or exosome treatment, seek medical care first. The FDA encourages reports to its MedWatch program. [5] In the US, call 911 for an emergency.

References

Systematic review of clinical studies using cell-derived extracellular vesicles, Curr Res Transl Med 2026 (PubMed 41349432). Read 2026-10-22.
FDA, Important Patient and Consumer Information About Regenerative Medicine Therapies. Read 2026-10-22.
FDA, Approved Cellular and Gene Therapy Products (current as of 09/17/2026). Read 2026-10-22.
FDA, Public Safety Notification on Exosome Products. Read 2026-10-22.
FDA, Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. Read 2026-10-22.

Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.